Germ cell tumours of the testis: Prognostic study;Tumeurs germinales du testicule : Étude pronostique

Progres en Urologie

Volumn 13, Issue 1, 2003, Pages 92-97

  Miladi, Makram ^a   Peyromaure, Michaël ^a   Remi, Julien ^a   Beuzeboc, Philippe ^a   Debre, Bernard ^a   Zerbib, Marc ^a  

^a Institut Cochin   (France)

Author keywords

Cancer of the testis; Germ cell tumour; Non seminomatous tumour; Prognosis; Seminoma

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CONTROLLED STUDY; DEATH; DISEASE COURSE; FOLLOW UP; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MINIMAL RESIDUAL DISEASE; ORCHIECTOMY; PROGNOSIS; SEMINOMA; TESTIS TUMOR; TUMOR CLASSIFICATION; CANCER STAGING; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY; TIME;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; GERMINOMA; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 0042305396     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ALEXANDRE J., FIZAZI K., MAHE C., CULINE S., DROZ J.P., THEODORE C., TERRIER-LACOMBE M.J. : Stage I non-seminomatous germ-cell tumours of the testis : identification of a subgroup of patients with a very low risk of relapse. Eur. J. Cancer, 2001, 37, 576-582.
2. BEHNIA M., FOSTER R., EINHORN L.H., DONOHUE J., NICHOLS C.R. : Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer : the Indiana University experience. Eur. J. Cancer, 2000, 36, 472-475.
3. CULINE S., THEODORE C., COURT B.H., PERRIN J.L., DROZ J.P. : Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis. Br. J. Urol., 1997, 79, 258-262.
4. DE LA TAILLE A., HOULGATTE A., HOUDELETTE P., BERLIZOT P., LANFREY P., ATGER M., FOURNIER R., ARBORIO M. : Place de la biopsie testiculaire dans la recherche d'un carcinome in situ. Prog. Urol., 1997, 7, 209-214.
5. DONG C., LONNSTEDT I., HEMMINKI K. : Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur. J. Cancer, 2001, 37, 1878-1885.
6. FRANCIS R., BOWER M., BRUNSTROM G., HOLDEN L., NEWLANDS E.S., RUSTlN G.J.S., SECKL M.J. : Surveillance for stage I testicular germ cell tumors : results and cost benefit analysis of management options. Eur. J. Cancer. 2000, 36, 1925-1932.
7. GERMA LLUCH J.R., CLIMENT M.A., VILLAVICENCIO H., GOMEZ DE SEGURA G., BLANCO R., MERCEDES A., DE ANDRES L., SOLE BALCELLS J. : Treatement of stage I testicular tumours. Br. J. Urol., 1993, 71, 473-477.
8. HENDRY W.F., A'HERN R.P., HETHERINGTON J.W., PECKHAM M.J., DEARNALEY D.P., HORWICH A. : Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br. J. Urol. 1993, 71, 208-213.
9. HERMES E.R., HARSTAD K., FOSSA S.D. : Changing incidence and delay of testicular cancer in southern Norway (1981-1992). Eur. Urol., 1996, 30, 349-357.
10. HORWICH A., PECKHAM M.J. : Surveillance after orchidectomy for clinical germ-cell tumours of the testis. Prog. Clin. Biol. Res., 1988, 269, 471-479.
11. KLEIN E.A. Tumor markers in testis cancer. Urol. Clin. North. Am., 1993, 20, 67-73.
12. KLEPP O., DAHL O., FLODGREN P., STIERNER U., OLSSON A.M., OLDBRING J., NILSSON S., DAEHLIN L., TORNBLOM M., SMALAND R., STARKHAMMAR H., ABRAMSSON L., WIST E., RAABE N., EDEKLING T., CAVALLIN-STAHL E. : Risk-adapted treatment of clinical stage I non-seminoma testis cancer. Eur. J. Cancer, 1997, 33, 1038-1044.
13. PILAR LACUNA M., PIZZOCARO G., KLEPP O., ALGABA F., KISBENEDEK L., LEIVA O. and the EAU working group on oncological urology. EAU guidelines on testicular cancer. Eur. Urol., 2001, 40, 102-110.
14. RAGHAVAN D. : Active surveillance for stage I testis cancer : attaining maturity at 21 years. Eur. J. Cancer. 2000, 36, 1891-1894.
15. SONNEVELD D.J.A., SLEIJFER D.T., KOOPS H.S., SIJMONS R.H, VAN DER GRAAF W.T.A, SLUITER W.J., HOEKSTRA H.J. : Familial testicular cancer in a single-center population. Eur. J. Cancer, 1999, 35, 1368-1373.
16. SPERMON J.R., ROELEVELD T.A., VAN DER POEL H.G., HULSBERGEN-VAN DE KAA C.A., TEN BOKKEL HUININK W.W., VAN DE VIJVER M., WITJES J.A., HORENBLAS S. : Comparison of surveillance and retroperitoneal lymph node dissection in stage I nonseminomatous germ cell tumors. Urology, 2002, 59, 923-929.
17. STERNBERG C.N. : The management of stage I testis cancer. Urol. Clin. North. Am., 1998, 25, 435-449.
18. THURET R., HOULGATTE A., FOURNIER R., DESGRAND CHAMPS F., MASZELIN P., GAILLARD J.F. : Progression des tumeurs germinales non séminomateuses de stade I sous surveillance. Place de la tomographie à émission de positons. Prog. Urol., 2000, 10, 1224-1227.